Citation: A. Clary et al., TRANSCRIPTIONAL DOWN-REGULATION OF C-MYC EXPRESSION IN AN ERYTHROLEUKEMIC CELL-LINE, K562, AND ITS DOXORUBICIN-RESISTANT VARIANT BY 2 TOPOISOMERASE-II INHIBITORS, DOXORUBICIN AND AMSACRINE, Anti-cancer drugs, 9(3), 1998, pp. 245-254
Authors:
POURQUIER P
MONTAUDON D
HUET S
LARRUE A
CLARY A
ROBERT J
Citation: P. Pourquier et al., DOXORUBICIN-INDUCED ALTERATIONS OF C-MYC AND C-JUN GENE-EXPRESSION INRAT GLIOBLASTOMA CELLS - ROLE OF C-JUN IN DRUG-RESISTANCE AND CELL-DEATH, Biochemical pharmacology, 55(12), 1998, pp. 1963-1971
Authors:
CHEVILLARD S
VIELH P
VALIDIRE P
MARIE JP
FAUSSAT AM
BARBU V
BAYLE C
BENARD J
BONNAL C
BOUTONNAT J
CALVO F
CHARRIER J
CLARY A
COLOSETTI P
DANELMOORE L
DECREMOUX P
DELVINCOURT C
FINATDUCLOS F
GENNE P
KATAKI A
KOUYOUMDJIAN JC
LACAVE R
MAUGARD C
MERLIN JL
MOUSSEAU M
PINGUET F
QUILLIEN V
RAPHAEL M
RICHARD B
VERRELLE P
ROBERT J
Citation: S. Chevillard et al., FRENCH MULTICENTRIC EVALUATION OF MDR1 GENE-EXPRESSION BY RT-PCR IN LEUKEMIA AND SOLID TUMORS - STANDARDIZATION OF RT-PCR AND PRELIMINARY COMPARISONS BETWEEN RT-PCR AND IMMUNOHISTOCHEMISTRY IN SOLID TUMORS, Leukemia, 11(7), 1997, pp. 1095-1106